Hot Topics
$5.35 million award in insurance company bad faith case
– Read the case summary
"Job-bias cases surge in Colorado, feds say"
– The Denver Post
"FedEx Sued For Not Letting Workers Clock In On Time"
"U.S. Supreme Court upholds right to recover compensation from drug companies for injuries"
– "Wyeth v. Levine Opinion"
– "Court allows drug label lawsuit"
– Wyeth Press Release
"Gadolinium law suits picks up pace"
– Missouri Lawyers Weekly
Wal-Mart Class Action Wage Lawsuits
"Attorney Michael Burg Leads the Hunt for Culprits in Economic Meltdown"
Janet Abaray Spearheads Class Action Suit Against Bengals
Explosion Accidents:
"Pooch alive after
Breck blast"
– Denver Post
"Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products"
– FDA
Yamaha Rhino ATV Rollover Accidents
and Injuries
"UBS Hit by
Another Lawsuit"
– Ben Levinsohn, BusinessWeek
"Hedge Funds
Frozen Shut"
– Matthew Goldstein, BusinessWeek
"MRI Contrast Can Cause Disease – Gadolinium Blamed
For Problems"
– Dayle Cedars
7News, Denver, CO
Results
$5,350,000
Jury awards a Burg Simpson client $5.35 million for Bad Faith Breach of Insurance Contract.
$1,300,000
Jury award to Englewood company to total more than $1 million for breach of fiduciary duties in Shareholder Class Action Case.
$690,000,000
Global settlement with Eli Lilly and Company regarding its product Zyprexa negotiated by a plaintiffs' attorney group including members of Burg Simpson.
$5,800,000
Hines, et al, vs. Cody Gas Company, et al: verdict for injuries, damages, losses from gas explosion.
CLICK HERE FOR MORE INFORMATION
Our Offices
40 Inverness Drive East
Denver, CO 80112
Phone: 303.792.5595
Fax: 303.708.0527
WYOMING OFFICE
Phone: 307.527.7891
Fax: 307.527.7897
OHIO OFFICE
Phone: 513.852.5600
Fax: 513.852.5611
ARIZONA OFFICE
Phone: 602.508.6040
Home > Defective Drugs > Vioxx
Vioxx Litigation Attorneys
in Colorado and Nationwide
Vioxx (generic name: rofecoxib) is a is a Cox-2 inhibitor in the same drug class as Celebrex and Bextra. The FDA approved Vioxx in May 1999 following various trials and tests. Vioxx was marketed based upon the claim that it could provide the same effects of a non-steroidal anti-inflammatory drug NSAID) without causing the gastric problems that commonly came with traditional NSAIDs.Then, in September 2004, continued testing indicated that Vioxx reduced the risk of stomach problems in patients but significantly increased the risk of heart attacks and strokes. On September 30, 2004 Merck announced the worldwide withdrawal of Vioxx from the market. Contrary to earlier reports that increased heart risks appeared after more than 18 months' worth of use, the evidence now shows that heart risks could occur after as few as three months of Vioxx use.
Burg Simpson has significant experience with Vioxx cases. Michael S. Burg was appointed to the Vioxx MDL State Liaison Committee, which coordinates state and federal Vioxx litigation.
To date, a number of Vioxx cases have been tried. In several cases, the plaintiffs have received large verdicts, but in an equal number of trials Merck has obtained a defense verdict.
Click to download the article featured in Law Week Colorado:
"At Vioxx's End – Most Who Qualify Will Take Deal, Burg Predicts"
If you believe you have suffered a claim because you used Vioxx, please call or email us today for a free consultation. At Burg Simpson Eldredge Hersh & Jardine, P.C., our Colorado attorneys represent people who have suffered injuries because of dangerous drugs like Vioxx.
Return to the Defective Drugs Section
